Migraine Relief Tablet
Product Images NDC 83324-099

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Migraine Relief (NDC 83324-099). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chain Drug Marketing Association, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (F1205a01qch R1 2024 0508)

Migraine Relief 250 mg Acetaminophen, 250 mg Aspirin (NSAID), and 65 mg Caffeine oral coated caplets by Chain Drug Marketing Association, Inc. The package contains 24 capsule-shaped tablets. The label includes information that it is comparable to the active ingredients in Excedrin Migraine and highlights its use as a pain reliever and pain reliever aid.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.